Lung Transplant Rejection Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Lung Transplant Rejection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

Lung Transplant Rejection
Sanofi180 enrolled80 locationsNCT06082037
Recruiting
Phase 2

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

Lung Transplant Rejection
University of Virginia60 enrolled1 locationNCT07046910
Recruiting

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Lung Transplant Rejection
University of Alberta700 enrolled11 locationsNCT02812290
Recruiting

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Lung Transplant; ComplicationsLung Transplant; Infection or InflammationLung Transplant Rejection+1 more
Duke University2,600 enrolled17 locationsNCT06399302
Recruiting
Not Applicable

Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients

Lung Transplant Rejection
Mayo Clinic100 enrolled1 locationNCT06824402
Recruiting
Phase 1

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

Chronic Lung DiseaseLung Transplant Rejection
Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana12 enrolled1 locationNCT06514378
Recruiting
Not Applicable

A Prospective Randomized Trial of ECP in Subclinical AMR

Lung Transplant RejectionAntibody-mediated Rejection
Medical University of Vienna80 enrolled7 locationsNCT06112951
Recruiting
Not Applicable

Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation

Lung Transplant; ComplicationsLung Transplant RejectionLung Transplant Failure+1 more
Hopital Foch900 enrolled1 locationNCT04837339
Recruiting

Exhaled Breath Particles in Lung Transplantation

Chronic Rejection of Lung TransplantLung Transplant RejectionPrimary Graft Dysfunction
Lund University Hospital150 enrolled1 locationNCT05375149